Privia Health Reports Strong Q1 Performance, Raises Attributed Lives Guidance
PRVA sits 32% above its 52-week low of $18.77.
Summary
Privia Health Group announced strong first-quarter 2026 financial results, including significant revenue and adjusted profitability growth, and raised its full-year guidance for Attributed Lives.
Key Events · Earnings and Guidance · PRVA
-
Strong Q1 Revenue Growth
Total revenue for the first quarter of 2026 increased by 25.8% year-over-year to $603.8 million.
-
Robust Profitability Growth
Adjusted EBITDA rose 36.3% to $36.7 million, and adjusted net income increased 22.3% to $24.3 million compared to the prior year's quarter.
-
Raised Attributed Lives Guidance
The company increased its full-year 2026 guidance for Value-Based Care Attributed Lives to a range of 1,600,000 - 1,625,000, up from the previous range of 1,550,000 - 1,600,000.
-
Reaffirmed Full-Year Outlook
Privia Health Group reiterated its full-year 2026 guidance for other key metrics, including GAAP revenue ($2.35 billion - $2.45 billion) and Adjusted EBITDA ($145 million - $155 million).
Analysis · PRVA · Industrial Applications And Services
Privia Health Group delivered robust first-quarter results, demonstrating significant growth across key operational and financial metrics. The substantial increases in revenue, operating income, and Adjusted EBITDA highlight strong execution. While GAAP net income saw a decline, this was primarily due to higher non-cash stock compensation expense, with adjusted net income showing healthy growth. The decision to raise full-year guidance for Attributed Lives, a critical operational metric, signals continued confidence in the company's value-based care model and growth trajectory. Reaffirming other financial guidance metrics further reinforces management's positive outlook for 2026.
How filings like this one have moved
In the 30 days to Sep 25, 2026, 30.7% of the 1654 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.70%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, PRVA was trading at $24.71 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $3B. The 52-week trading range was $18.77 to $26.51. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.